Related Experiment Video

Updated: Sep 12, 2025

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
11:00

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs

Published on: June 12, 2018

14.0K

CircRNA aptamer targets IGF2BP2 to overcome acquired BETi resistance

Christophe Nicot1

  • 1Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA. cnicot@kumc.edu.

Molecular Cancer
|August 10, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

639
PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins
12:24

PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins

Published on: July 2, 2010

53.6K

Related Experiment Videos

Last Updated: Sep 12, 2025

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
11:00

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs

Published on: June 12, 2018

14.0K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

639
PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins
12:24

PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins

Published on: July 2, 2010

53.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Experimental RNAi02:15

Experimental RNAi

6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K

Articles linked to this work by shared authors, journal, and citation graph.

c-Myc: Central regulator of autophagy and senescence in cancer.

Cancer letters·2026

Jab1 regulates HRR mRNA stability to modulate PARP inhibitor sensitivity in triple-negative breast cancer.

Molecular cancer·2025

EMT and cancer stem cells: Drivers of therapy resistance and promising therapeutic targets.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2025

TGF-β-driven EMT in cancer progression and drug resistance.

Cytokine & growth factor reviews·2025

PARP inhibition elicits NK cell-associated immune evasion via potentiating HLA-G expression in tumor.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2025

Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy.

Cytokine & growth factor reviews·2025

Ecosystem-matched reprogramming of the tumor-immune microenvironment to overcome cancer immunotherapy resistance.

Molecular cancer·2026

A targetable dependency on nonsense-mediated decay for cellular homeostasis and immune control in small cell lung cancer.

Molecular cancer·2026

Programmable ZBTB7A RNA N6-methyladenosine site-specific demethylation suppresses colorectal cancer liver metastasis.

Molecular cancer·2026

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Molecular cancer·2026

Advances in improving cancer immunotherapy with nanotechnology: from smart nanoparticles to synergistic combination strategies.

Molecular cancer·2026

Radiotherapy and tertiary lymphoid structures: balancing immune activation and immune damage in cancer immunotherapy.

Molecular cancer·2026

VAC-Stent as salvage therapy after failed surgical repair and self-expandable metal stent treatment in esophageal perforation.

Revista espanola de enfermedades digestivas·2026

Innovative Solutions for Obesity: Evaluating gastric bypass stents in Postlaparoscopic Sleeve Gastrectomy Weight Management.

Endoscopy international open·2026

Long-Term Outcome After Pulsed Field Ablation for Atrial Fibrillation Across an Atrial Septal Defect Closure Device: A 20-Month Follow-Up Case Report.

Clinical case reports·2026

Balloon-Assisted Maturation in Salvaging Stenosed Arteriovenous Fistulas: A Case Series and Clinical Insights.

Cureus·2026

Cardiomyoplasty: A renaissance of an abandoned technique.

The International journal of artificial organs·2026

Enhancing spatial neglect screening: Preliminary evidence from a modified Baking Tray Test.

Applied neuropsychology. Adult·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us